Are you over 18 and want to see adult content?
More Annotations
![A complete backup of kw.be/nieuws/cultuur-en-media/kandidaten-van-de-mol-zijn-bekend-twee-west-vlaamse-dames-vallen-op/article-n](https://www.archivebay.com/archive2/c5dc57a5-06f7-4a00-be67-1c31116ed018.png)
A complete backup of kw.be/nieuws/cultuur-en-media/kandidaten-van-de-mol-zijn-bekend-twee-west-vlaamse-dames-vallen-op/article-n
Are you over 18 and want to see adult content?
![A complete backup of www.espn.com/soccer/report?gameId=560961](https://www.archivebay.com/archive2/734fb514-155a-4de3-b50d-0832e2955fac.png)
A complete backup of www.espn.com/soccer/report?gameId=560961
Are you over 18 and want to see adult content?
Favourite Annotations
![A complete backup of https://richeisenshow.com](https://www.archivebay.com/archive6/images/89ed32bd-43ec-4ab0-88a7-2280f4d1fd0e.png)
A complete backup of https://richeisenshow.com
Are you over 18 and want to see adult content?
![A complete backup of https://tittorrents.com](https://www.archivebay.com/archive6/images/932448c7-73de-4fa1-9c91-78f604cb1a84.png)
A complete backup of https://tittorrents.com
Are you over 18 and want to see adult content?
![A complete backup of https://worldses.org](https://www.archivebay.com/archive6/images/4d7e2a66-b5f0-4e14-948f-8b2c10fb2999.png)
A complete backup of https://worldses.org
Are you over 18 and want to see adult content?
![A complete backup of https://aquafold.com](https://www.archivebay.com/archive6/images/38aaba1e-0404-40ad-9ed2-2406f7c17ba2.png)
A complete backup of https://aquafold.com
Are you over 18 and want to see adult content?
![A complete backup of https://hippocampuspress.com](https://www.archivebay.com/archive6/images/240c6fc8-c213-4df1-8d43-8a82fdbe11d2.png)
A complete backup of https://hippocampuspress.com
Are you over 18 and want to see adult content?
![A complete backup of https://joebeef.ca](https://www.archivebay.com/archive6/images/423b705c-fac5-453b-a72a-9b295747a9da.png)
A complete backup of https://joebeef.ca
Are you over 18 and want to see adult content?
![A complete backup of https://malditolag.com.br](https://www.archivebay.com/archive6/images/f6df32ed-fc3f-45af-864e-5beda8e090f1.png)
A complete backup of https://malditolag.com.br
Are you over 18 and want to see adult content?
![A complete backup of https://palmerstoncellars.com](https://www.archivebay.com/archive6/images/efed1331-7c04-49ac-a3a9-291b62892442.png)
A complete backup of https://palmerstoncellars.com
Are you over 18 and want to see adult content?
![A complete backup of https://fundable.com](https://www.archivebay.com/archive6/images/4ec6ed77-a8ba-4d67-86fe-31715d8ce0d0.png)
A complete backup of https://fundable.com
Are you over 18 and want to see adult content?
![A complete backup of https://eisomoy24.com](https://www.archivebay.com/archive6/images/83e9f057-2718-4ce0-b709-7400ef5179ec.png)
A complete backup of https://eisomoy24.com
Are you over 18 and want to see adult content?
![A complete backup of https://lokaltvader.se](https://www.archivebay.com/archive6/images/656916fc-109a-4073-9c1d-dd4724d2cfd1.png)
A complete backup of https://lokaltvader.se
Are you over 18 and want to see adult content?
Text
ALKEM LABORATORIES
Alkem markets and sells products in the United States under our wholly owned subsidiary – Ascend. Other international operations include markets like Australia, Europe, Southeast Asia, Latin America, Africa and CIS. Our products are marketed in about 50 international markets directly through our subsidiaries and indirectly through activeALKEM LABORATORIES
Alkem Postal Ballot Results 04.04.2020. Public Notice for Declaration of Record Date for Interim Dividend - FY 2019-20. Newspaper Advertisements. E-paper - 45th AGM Notice. E-paper - Notice of Board Meeting QE 30.06.2019. E-paper -Extract of Financial Result for the QE31.12.2019.
ALKEM LABORATORIES
Q4 Jan to Mar - 2021. Q4FY21 Press Release. Consolidated Results Mar 21. Standalone Results Mar 21.ALKEM LABORATORIES
Alkem Laboratories Ltd is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical generics, formulations and nutraceuticalsALKEM LABORATORIES
Annual Reports. BSE. NSE. ALKEM alkem laboratories limited. 3106.35 4.07 % (121.45) Note: The displayed data may not be real time due tostreaming delays.
ALKEM LABORATORIES
Dermatology. Dermatology and Aesthetics has always been an important Therapy Area (TA) for Alkem. We cater to this segment by integration, innovation and enhancement of our diverse Dermatology & Cosmetology portfolio. Our portfolio includes products for acne, skin infections, melasma, moisturizers, dermatitis, alopecia and skin revitalization.ALKEM LABORATORIES
Diligent and effective international regulatory-compliant operations. Broad and growing portfolio of cGMP API’s available. Contract research, development and international cGMP compliant manufacturing capabilities and services. Full complement of GMP manufacturing technologies and supporting QC analytical capabilities.ALKEM LABORATORIES
UNITED STATES. Being the focal point of our international operations, we manufacture and supply a wide-range of generics and branded formulations in the United States. Our primary subsidiary, Ascend is ranked amongst the fastest growing companies in terms of generic drugs sales. Our other assets include Norac Pharma in California for APIALKEM LABORATORIES
4. Strategies of the Company. Details of Familiarization Programmes held during 2020/2021. The Company has been briefing the independent directors on the issues concerning the industry, to which the Company belongs, developments which takes place and the ALKEM LABORATORIESCORPORATE INFOGLOBAL PRESENCER & DMANUFACTURINGINVESTOR DESKMEDIA ROOM Four decades of empowering wellness. With an illustrious journey which stands at striking distance of completing 5 decades, Alkem Laboratories commands the status of one of world's leading global pharmaceutical formulation development, manufacturing andALKEM LABORATORIES
Alkem markets and sells products in the United States under our wholly owned subsidiary – Ascend. Other international operations include markets like Australia, Europe, Southeast Asia, Latin America, Africa and CIS. Our products are marketed in about 50 international markets directly through our subsidiaries and indirectly through activeALKEM LABORATORIES
Alkem Postal Ballot Results 04.04.2020. Public Notice for Declaration of Record Date for Interim Dividend - FY 2019-20. Newspaper Advertisements. E-paper - 45th AGM Notice. E-paper - Notice of Board Meeting QE 30.06.2019. E-paper -Extract of Financial Result for the QE31.12.2019.
ALKEM LABORATORIES
Q4 Jan to Mar - 2021. Q4FY21 Press Release. Consolidated Results Mar 21. Standalone Results Mar 21.ALKEM LABORATORIES
Alkem Laboratories Ltd is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical generics, formulations and nutraceuticalsALKEM LABORATORIES
Annual Reports. BSE. NSE. ALKEM alkem laboratories limited. 3106.35 4.07 % (121.45) Note: The displayed data may not be real time due tostreaming delays.
ALKEM LABORATORIES
Dermatology. Dermatology and Aesthetics has always been an important Therapy Area (TA) for Alkem. We cater to this segment by integration, innovation and enhancement of our diverse Dermatology & Cosmetology portfolio. Our portfolio includes products for acne, skin infections, melasma, moisturizers, dermatitis, alopecia and skin revitalization.ALKEM LABORATORIES
Diligent and effective international regulatory-compliant operations. Broad and growing portfolio of cGMP API’s available. Contract research, development and international cGMP compliant manufacturing capabilities and services. Full complement of GMP manufacturing technologies and supporting QC analytical capabilities.ALKEM LABORATORIES
UNITED STATES. Being the focal point of our international operations, we manufacture and supply a wide-range of generics and branded formulations in the United States. Our primary subsidiary, Ascend is ranked amongst the fastest growing companies in terms of generic drugs sales. Our other assets include Norac Pharma in California for APIALKEM LABORATORIES
4. Strategies of the Company. Details of Familiarization Programmes held during 2020/2021. The Company has been briefing the independent directors on the issues concerning the industry, to which the Company belongs, developments which takes place and theALKEM LABORATORIES
Alkem markets and sells products in the United States under our wholly owned subsidiary – Ascend. Other international operations include markets like Australia, Europe, Southeast Asia, Latin America, Africa and CIS. Our products are marketed in about 50 international markets directly through our subsidiaries and indirectly through activeALKEM LABORATORIES
Alkem Cytomed offers three biosimilar drugs i.e. Rituximab (Cytomab), Bevacizumab (Advamab) and Trastuzumab (Hersima). All of these are monoclonal antibodies. Rituximab is highly recommended by oncologists as targeted therapy for treatment of one of the cancer Non-Hodgkin lymphoma (NHL) and autoimmune disorder like rheumatoid arthritis (RA).ALKEM LABORATORIES
About Alkem Labs. A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a sparkthat could
ALKEM LABORATORIES
Q4 Jan to Mar - 2021. Q4FY21 Press Release. Consolidated Results Mar 21. Standalone Results Mar 21.ALKEM LABORATORIES
Livoerb . Livoerb is a quality Hepatoprotective tonic from the house of Alkem. Livoerb helps in liver cleansing and improves appetite. Livoerb is an Ayurvedic medicine and it is available in multiple variants which are Livoerb Syrup, Livoerb DS Syrup, Livoerb Sugar Freeand Livoerb Zyme.
ALKEM LABORATORIES
We are a high quality focused organization. Alkem’s vision and culture of high quality obsession reflects in its operations. Our manufacturing operations are focused on producing generics, branded generics, over-the-counter (OTC) products, Active Pharmaceutical Ingredients (APIs) and nutraceuticals. These are available in fullrange of dosage
ALKEM
ALKEM is an inclusive place to work where innovation is encouraged and people feel valued while maintaining their uniqueness. Some of our major successful team efforts include the grand IPO success, The UDAAN project – A multi functional cost reduction project and Launch ofour OTC Business.
ALKEM LABORATORIES
Alkem commands around 6% of the total revenue generated by this TA. Presently, Alkem is the 3rd largest company in GI Therapy Area (TA) of the Indian Pharmaceutical Market (IPM). Over the years, we have developed several products for GI disorders like GERD, gastric ulcers, constipation, hyperacidity, diarrhoea, worm infestation etc.ALKEM LABORATORIES
Alkem Laboratories Ltd is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical generics, formulations and nutraceuticalsALKEM LABORATORIES
The Pharma Network LLC and Ascend Laboratories LLC_-USA_FS_2018-19 ALKEM LABORATORIESCORPORATE INFOGLOBAL PRESENCER & DMANUFACTURINGINVESTOR DESKMEDIA ROOM Four decades of empowering wellness. With an illustrious journey which stands at striking distance of completing 5 decades, Alkem Laboratories commands the status of one of world's leading global pharmaceutical formulation development, manufacturing andALKEM LABORATORIES
Alkem markets and sells products in the United States under our wholly owned subsidiary – Ascend. Other international operations include markets like Australia, Europe, Southeast Asia, Latin America, Africa and CIS. Our products are marketed in about 50 international markets directly through our subsidiaries and indirectly through activeALKEM LABORATORIES
Alkem Cytomed offers three biosimilar drugs i.e. Rituximab (Cytomab), Bevacizumab (Advamab) and Trastuzumab (Hersima). All of these are monoclonal antibodies. Rituximab is highly recommended by oncologists as targeted therapy for treatment of one of the cancer Non-Hodgkin lymphoma (NHL) and autoimmune disorder like rheumatoid arthritis (RA).ALKEM LABORATORIES
Q4 Jan to Mar - 2021. Q4FY21 Press Release. Consolidated Results Mar 21. Standalone Results Mar 21.ALKEM LABORATORIES
Alkem Postal Ballot Results 04.04.2020. Public Notice for Declaration of Record Date for Interim Dividend - FY 2019-20. Newspaper Advertisements. E-paper - 45th AGM Notice. E-paper - Notice of Board Meeting QE 30.06.2019. E-paper -Extract of Financial Result for the QE31.12.2019.
ALKEM LABORATORIES
Alkem Laboratories Ltd is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical generics, formulations and nutraceuticalsALKEM LABORATORIES
Alkem features amongst the top 10 companies in the Neuro/CNS Therapy Area (TA). We offer therapy for Alzheimer’s, Dementia, Stroke, Migraine, Epilepsy, Depression and Neuropathic Pain Management. Over the last four years, we have significantly outperformedALKEM LABORATORIES
Annual Reports. BSE. NSE. ALKEM alkem laboratories limited. 3106.35 4.07 % (121.45) Note: The displayed data may not be real time due tostreaming delays.
ALKEM LABORATORIES
Diligent and effective international regulatory-compliant operations. Broad and growing portfolio of cGMP API’s available. Contract research, development and international cGMP compliant manufacturing capabilities and services. Full complement of GMP manufacturing technologies and supporting QC analytical capabilities.ALKEM LABORATORIES
UNITED STATES. Being the focal point of our international operations, we manufacture and supply a wide-range of generics and branded formulations in the United States. Our primary subsidiary, Ascend is ranked amongst the fastest growing companies in terms of generic drugs sales. Our other assets include Norac Pharma in California for API ALKEM LABORATORIESCORPORATE INFOGLOBAL PRESENCER & DMANUFACTURINGINVESTOR DESKMEDIA ROOM Four decades of empowering wellness. With an illustrious journey which stands at striking distance of completing 5 decades, Alkem Laboratories commands the status of one of world's leading global pharmaceutical formulation development, manufacturing andALKEM LABORATORIES
Alkem markets and sells products in the United States under our wholly owned subsidiary – Ascend. Other international operations include markets like Australia, Europe, Southeast Asia, Latin America, Africa and CIS. Our products are marketed in about 50 international markets directly through our subsidiaries and indirectly through activeALKEM LABORATORIES
Alkem Cytomed offers three biosimilar drugs i.e. Rituximab (Cytomab), Bevacizumab (Advamab) and Trastuzumab (Hersima). All of these are monoclonal antibodies. Rituximab is highly recommended by oncologists as targeted therapy for treatment of one of the cancer Non-Hodgkin lymphoma (NHL) and autoimmune disorder like rheumatoid arthritis (RA).ALKEM LABORATORIES
Q4 Jan to Mar - 2021. Q4FY21 Press Release. Consolidated Results Mar 21. Standalone Results Mar 21.ALKEM LABORATORIES
Alkem Postal Ballot Results 04.04.2020. Public Notice for Declaration of Record Date for Interim Dividend - FY 2019-20. Newspaper Advertisements. E-paper - 45th AGM Notice. E-paper - Notice of Board Meeting QE 30.06.2019. E-paper -Extract of Financial Result for the QE31.12.2019.
ALKEM LABORATORIES
Alkem Laboratories Ltd is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical generics, formulations and nutraceuticalsALKEM LABORATORIES
Alkem features amongst the top 10 companies in the Neuro/CNS Therapy Area (TA). We offer therapy for Alzheimer’s, Dementia, Stroke, Migraine, Epilepsy, Depression and Neuropathic Pain Management. Over the last four years, we have significantly outperformedALKEM LABORATORIES
Annual Reports. BSE. NSE. ALKEM alkem laboratories limited. 3106.35 4.07 % (121.45) Note: The displayed data may not be real time due tostreaming delays.
ALKEM LABORATORIES
Diligent and effective international regulatory-compliant operations. Broad and growing portfolio of cGMP API’s available. Contract research, development and international cGMP compliant manufacturing capabilities and services. Full complement of GMP manufacturing technologies and supporting QC analytical capabilities.ALKEM LABORATORIES
UNITED STATES. Being the focal point of our international operations, we manufacture and supply a wide-range of generics and branded formulations in the United States. Our primary subsidiary, Ascend is ranked amongst the fastest growing companies in terms of generic drugs sales. Our other assets include Norac Pharma in California for APIALKEM LABORATORIES
Alkem markets and sells products in the United States under our wholly owned subsidiary – Ascend. Other international operations include markets like Australia, Europe, Southeast Asia, Latin America, Africa and CIS. Our products are marketed in about 50 international markets directly through our subsidiaries and indirectly through activeALKEM LABORATORIES
Alkem's competitive advantage as a manufacturer stems from its world class facilities. Quality and Alkem are synonymous! For us patient centricity is the foundation on which the organisation rests. Our every action is triggered by empathy for patients and the unflinching commitment to fulfil their unmet needs.ALKEM LABORATORIES
Dermatology. Dermatology and Aesthetics has always been an important Therapy Area (TA) for Alkem. We cater to this segment by integration, innovation and enhancement of our diverse Dermatology & Cosmetology portfolio. Our portfolio includes products for acne, skin infections, melasma, moisturizers, dermatitis, alopecia and skin revitalization.ALKEM LABORATORIES
Livoerb . Livoerb is a quality Hepatoprotective tonic from the house of Alkem. Livoerb helps in liver cleansing and improves appetite. Livoerb is an Ayurvedic medicine and it is available in multiple variants which are Livoerb Syrup, Livoerb DS Syrup, Livoerb Sugar Freeand Livoerb Zyme.
ALKEM LABORATORIES
We are a high quality focused organization. Alkem’s vision and culture of high quality obsession reflects in its operations. Our manufacturing operations are focused on producing generics, branded generics, over-the-counter (OTC) products, Active Pharmaceutical Ingredients (APIs) and nutraceuticals. These are available in fullrange of dosage
ALKEM LABORATORIES
Alkem Urology was launched in July 2017 to cater to the Super specialty segment of Urologist, within the span of 24 Months Alkem Urology has established itself as a serious player in the market ranking 11th in RPM (IMS July 19). We have a key presence in Anti BPH, Stone Management, OAB (Over active bladder) and Erectile dysfunctiontherapies
ALKEM LABORATORIES
4. Strategies of the Company. Details of Familiarization Programmes held during 2020/2021. The Company has been briefing the independent directors on the issues concerning the industry, to which the Company belongs, developments which takes place and theALKEM LABORATORIES
Alkem is a socially responsible organization that’s actively involved in the betterment of the society. We have adopted many villages across the country. Our team is working persistently to provide basic infrastructure facilities in these villages. Theseinclude, drinking
ALKEM LABORATORIES
The Pharma Network LLC and Ascend Laboratories LLC_-USA_FS_2018-19ALKEM LABORATORIES
Unpaid / Unclaimed Dividend Details. Financial Year 2015-2016. Second Interim Dividend. Financial Year 2016-2017. Interim Dividend. Final Dividend. Financial Year 2017-2018. Interim Dividend. Final Dividend. ALKEM LABORATORIESCORPORATE INFOGLOBAL PRESENCER & DMANUFACTURINGINVESTOR DESKMEDIA ROOM Four decades of empowering wellness. With an illustrious journey which stands at striking distance of completing 5 decades, Alkem Laboratories commands the status of one of world's leading global pharmaceutical formulation development, manufacturing andALKEM LABORATORIES
Alkem Cytomed offers three biosimilar drugs i.e. Rituximab (Cytomab), Bevacizumab (Advamab) and Trastuzumab (Hersima). All of these are monoclonal antibodies. Rituximab is highly recommended by oncologists as targeted therapy for treatment of one of the cancer Non-Hodgkin lymphoma (NHL) and autoimmune disorder like rheumatoid arthritis (RA).ALKEM LABORATORIES
Alkem Laboratories Ltd is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical generics, formulations and nutraceuticalsALKEM LABORATORIES
Livoerb . Livoerb is a quality Hepatoprotective tonic from the house of Alkem. Livoerb helps in liver cleansing and improves appetite. Livoerb is an Ayurvedic medicine and it is available in multiple variants which are Livoerb Syrup, Livoerb DS Syrup, Livoerb Sugar Freeand Livoerb Zyme.
ALKEM LABORATORIES
Q4 Jan to Mar - 2021. Q4FY21 Press Release. Consolidated Results Mar 21. Standalone Results Mar 21.ALKEM LABORATORIES
Alkem Urology was launched in July 2017 to cater to the Super specialty segment of Urologist, within the span of 24 Months Alkem Urology has established itself as a serious player in the market ranking 11th in RPM (IMS July 19). We have a key presence in Anti BPH, Stone Management, OAB (Over active bladder) and Erectile dysfunctiontherapies
ALKEM LABORATORIES
Alkem Postal Ballot Results 04.04.2020. Public Notice for Declaration of Record Date for Interim Dividend - FY 2019-20. Newspaper Advertisements. E-paper - 45th AGM Notice. E-paper - Notice of Board Meeting QE 30.06.2019. E-paper -Extract of Financial Result for the QE31.12.2019.
ALKEM LABORATORIES
Diligent and effective international regulatory-compliant operations. Broad and growing portfolio of cGMP API’s available. Contract research, development and international cGMP compliant manufacturing capabilities and services. Full complement of GMP manufacturing technologies and supporting QC analytical capabilities.ALKEM LABORATORIES
Annual Reports. BSE. NSE. ALKEM alkem laboratories limited. 3106.35 4.07 % (121.45) Note: The displayed data may not be real time due tostreaming delays.
ALKEM LABORATORIES
UNITED STATES. Being the focal point of our international operations, we manufacture and supply a wide-range of generics and branded formulations in the United States. Our primary subsidiary, Ascend is ranked amongst the fastest growing companies in terms of generic drugs sales. Our other assets include Norac Pharma in California for API ALKEM LABORATORIESCORPORATE INFOGLOBAL PRESENCER & DMANUFACTURINGINVESTOR DESKMEDIA ROOM Four decades of empowering wellness. With an illustrious journey which stands at striking distance of completing 5 decades, Alkem Laboratories commands the status of one of world's leading global pharmaceutical formulation development, manufacturing andALKEM LABORATORIES
Alkem Cytomed offers three biosimilar drugs i.e. Rituximab (Cytomab), Bevacizumab (Advamab) and Trastuzumab (Hersima). All of these are monoclonal antibodies. Rituximab is highly recommended by oncologists as targeted therapy for treatment of one of the cancer Non-Hodgkin lymphoma (NHL) and autoimmune disorder like rheumatoid arthritis (RA).ALKEM LABORATORIES
Alkem Laboratories Ltd is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical generics, formulations and nutraceuticalsALKEM LABORATORIES
Livoerb . Livoerb is a quality Hepatoprotective tonic from the house of Alkem. Livoerb helps in liver cleansing and improves appetite. Livoerb is an Ayurvedic medicine and it is available in multiple variants which are Livoerb Syrup, Livoerb DS Syrup, Livoerb Sugar Freeand Livoerb Zyme.
ALKEM LABORATORIES
Q4 Jan to Mar - 2021. Q4FY21 Press Release. Consolidated Results Mar 21. Standalone Results Mar 21.ALKEM LABORATORIES
Alkem Urology was launched in July 2017 to cater to the Super specialty segment of Urologist, within the span of 24 Months Alkem Urology has established itself as a serious player in the market ranking 11th in RPM (IMS July 19). We have a key presence in Anti BPH, Stone Management, OAB (Over active bladder) and Erectile dysfunctiontherapies
ALKEM LABORATORIES
Alkem Postal Ballot Results 04.04.2020. Public Notice for Declaration of Record Date for Interim Dividend - FY 2019-20. Newspaper Advertisements. E-paper - 45th AGM Notice. E-paper - Notice of Board Meeting QE 30.06.2019. E-paper -Extract of Financial Result for the QE31.12.2019.
ALKEM LABORATORIES
Diligent and effective international regulatory-compliant operations. Broad and growing portfolio of cGMP API’s available. Contract research, development and international cGMP compliant manufacturing capabilities and services. Full complement of GMP manufacturing technologies and supporting QC analytical capabilities.ALKEM LABORATORIES
Annual Reports. BSE. NSE. ALKEM alkem laboratories limited. 3106.35 4.07 % (121.45) Note: The displayed data may not be real time due tostreaming delays.
ALKEM LABORATORIES
UNITED STATES. Being the focal point of our international operations, we manufacture and supply a wide-range of generics and branded formulations in the United States. Our primary subsidiary, Ascend is ranked amongst the fastest growing companies in terms of generic drugs sales. Our other assets include Norac Pharma in California for APIALKEM LABORATORIES
Alkem markets and sells products in the United States under our wholly owned subsidiary – Ascend. Other international operations include markets like Australia, Europe, Southeast Asia, Latin America, Africa and CIS. Our products are marketed in about 50 international markets directly through our subsidiaries and indirectly through activeALKEM LABORATORIES
Q4 Jan to Mar - 2021. Q4FY21 Press Release. Consolidated Results Mar 21. Standalone Results Mar 21.ALKEM LABORATORIES
Office Suits 4th Floor Block-B Parklands Road. Nairobi Kenya. P.O. Box : 14999-00800. Philippines. Alkem Laboratories Corporation. 5/F Filipino Building, 135 Dela Rosa cor. Legaspi and Bolanos, Legaspi village, Makati, Metro Manila. Australia. Pharmacor Pty Ltd. ABN : 58 121 020 835 A : Suite 803, Level 8, Tower A, The Zenith, 821 PacificALKEM LABORATORIES
Head Office. Alkem Laboratories Limited. CIN: L00305MH1973PLC174201. Devashish Building, Alkem House, Senapati Bapat Road, Lower Parel,Mumbai - 400 013.
ALKEM LABORATORIES
Dermatology. Dermatology and Aesthetics has always been an important Therapy Area (TA) for Alkem. We cater to this segment by integration, innovation and enhancement of our diverse Dermatology & Cosmetology portfolio. Our portfolio includes products for acne, skin infections, melasma, moisturizers, dermatitis, alopecia and skin revitalization.ALKEM LABORATORIES
We are a high quality focused organization. Alkem’s vision and culture of high quality obsession reflects in its operations. Our manufacturing operations are focused on producing generics, branded generics, over-the-counter (OTC) products, Active Pharmaceutical Ingredients (APIs) and nutraceuticals. These are available in fullrange of dosage
ALKEM LABORATORIES
4. Strategies of the Company. Details of Familiarization Programmes held during 2020/2021. The Company has been briefing the independent directors on the issues concerning the industry, to which the Company belongs, developments which takes place and theALKEM LABORATORIES
Alkem commands around 6% of the total revenue generated by this TA. Presently, Alkem is the 3rd largest company in GI Therapy Area (TA) of the Indian Pharmaceutical Market (IPM). Over the years, we have developed several products for GI disorders like GERD, gastric ulcers, constipation, hyperacidity, diarrhoea, worm infestation etc.ALKEM
ALKEM is an inclusive place to work where innovation is encouraged and people feel valued while maintaining their uniqueness. Some of our major successful team efforts include the grand IPO success, The UDAAN project – A multi functional cost reduction project and Launch of our OTC Business. RECOGNITION at Alkem.ALKEM LABORATORIES
Alkem Laboratories has a strong commitment towards manufacturing quality products. The safety of pharmaceutical product may not be distinct, post effects of drug when used in combination of other drugs are generally unknown and safety concerned in different groups can be different as in young children, elderly patient, pregnant women. ALKEM LABORATORIESCORPORATE INFOGLOBAL PRESENCER & DMANUFACTURINGINVESTOR DESKMEDIA ROOM Four decades of empowering wellness. With an illustrious journey which stands at striking distance of completing 5 decades, Alkem Laboratories commands the status of one of world's leading global pharmaceutical formulation development, manufacturing and ALKEM LABORATORIESALKEM LABORATORIES Alkem markets and sells products in the United States under our wholly owned subsidiary – Ascend. Other international operations include markets like Australia, Europe, Southeast Asia, Latin America, Africa and CIS. Our products are marketed in about 50 international markets directly through our subsidiaries and indirectly through activeALKEM LABORATORIES
Alkem Cytomed offers three biosimilar drugs i.e. Rituximab (Cytomab), Bevacizumab (Advamab) and Trastuzumab (Hersima). All of these are monoclonal antibodies. Rituximab is highly recommended by oncologists as targeted therapy for treatment of one of the cancer Non-Hodgkin lymphoma (NHL) and autoimmune disorder like rheumatoid arthritis (RA).ALKEM LABORATORIES
Alkem Postal Ballot Results 04.04.2020. Public Notice for Declaration of Record Date for Interim Dividend - FY 2019-20. Newspaper Advertisements. E-paper - 45th AGM Notice. E-paper - Notice of Board Meeting QE 30.06.2019. E-paper -Extract of Financial Result for the QE31.12.2019.
ALKEM LABORATORIESALKEM LABORATORIESALKEM INDIAALKEM LABS USAALKEM LABSHARE PRICE
Alkem Laboratories Ltd is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical generics, formulations and nutraceuticalsALKEM LABORATORIES
Q4 Jan to Mar - 2021. Q4FY21 Press Release. Consolidated Results Mar 21. Standalone Results Mar 21.ALKEM LABORATORIES
Annual Reports. BSE. NSE. ALKEM alkem laboratories limited. 3106.35 4.07 % (121.45) Note: The displayed data may not be real time due tostreaming delays.
ALKEM LABORATORIESALKEM LABORATORIESALKEM LABORATORIES LTDALKEM INDIAALKEM PHARMAALKEM LABS USAALKEM ST LOUIS Diligent and effective international regulatory-compliant operations. Broad and growing portfolio of cGMP API’s available. Contract research, development and international cGMP compliant manufacturing capabilities and services. Full complement of GMP manufacturing technologies and supporting QC analytical capabilities.ALKEM LABORATORIES
Alkem continues to explore market opportunities through licensing arrangements and alliances to draw maximum value from such arrangements. For marketing alliances, Alkem works on non-infringement policies that respect the intellectual property rights of itspartners.
ALKEM LABORATORIES
Alkem commands around 6% of the total revenue generated by this TA. Presently, Alkem is the 3rd largest company in GI Therapy Area (TA) of the Indian Pharmaceutical Market (IPM). Over the years, we have developed several products for GI disorders like GERD, gastric ulcers, constipation, hyperacidity, diarrhoea, worm infestation etc. ALKEM LABORATORIESCORPORATE INFOGLOBAL PRESENCER & DMANUFACTURINGINVESTOR DESKMEDIA ROOM Four decades of empowering wellness. With an illustrious journey which stands at striking distance of completing 5 decades, Alkem Laboratories commands the status of one of world's leading global pharmaceutical formulation development, manufacturing and ALKEM LABORATORIESALKEM LABORATORIES Alkem markets and sells products in the United States under our wholly owned subsidiary – Ascend. Other international operations include markets like Australia, Europe, Southeast Asia, Latin America, Africa and CIS. Our products are marketed in about 50 international markets directly through our subsidiaries and indirectly through activeALKEM LABORATORIES
Alkem Cytomed offers three biosimilar drugs i.e. Rituximab (Cytomab), Bevacizumab (Advamab) and Trastuzumab (Hersima). All of these are monoclonal antibodies. Rituximab is highly recommended by oncologists as targeted therapy for treatment of one of the cancer Non-Hodgkin lymphoma (NHL) and autoimmune disorder like rheumatoid arthritis (RA).ALKEM LABORATORIES
Alkem Postal Ballot Results 04.04.2020. Public Notice for Declaration of Record Date for Interim Dividend - FY 2019-20. Newspaper Advertisements. E-paper - 45th AGM Notice. E-paper - Notice of Board Meeting QE 30.06.2019. E-paper -Extract of Financial Result for the QE31.12.2019.
ALKEM LABORATORIESALKEM LABORATORIESALKEM INDIAALKEM LABS USAALKEM LABSHARE PRICE
Alkem Laboratories Ltd is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical generics, formulations and nutraceuticalsALKEM LABORATORIES
Q4 Jan to Mar - 2021. Q4FY21 Press Release. Consolidated Results Mar 21. Standalone Results Mar 21.ALKEM LABORATORIES
Annual Reports. BSE. NSE. ALKEM alkem laboratories limited. 3106.35 4.07 % (121.45) Note: The displayed data may not be real time due tostreaming delays.
ALKEM LABORATORIESALKEM LABORATORIESALKEM LABORATORIES LTDALKEM INDIAALKEM PHARMAALKEM LABS USAALKEM ST LOUIS Diligent and effective international regulatory-compliant operations. Broad and growing portfolio of cGMP API’s available. Contract research, development and international cGMP compliant manufacturing capabilities and services. Full complement of GMP manufacturing technologies and supporting QC analytical capabilities.ALKEM LABORATORIES
Alkem continues to explore market opportunities through licensing arrangements and alliances to draw maximum value from such arrangements. For marketing alliances, Alkem works on non-infringement policies that respect the intellectual property rights of itspartners.
ALKEM LABORATORIES
Alkem commands around 6% of the total revenue generated by this TA. Presently, Alkem is the 3rd largest company in GI Therapy Area (TA) of the Indian Pharmaceutical Market (IPM). Over the years, we have developed several products for GI disorders like GERD, gastric ulcers, constipation, hyperacidity, diarrhoea, worm infestation etc.ALKEM LABORATORIES
Alkem Cytomed offers three biosimilar drugs i.e. Rituximab (Cytomab), Bevacizumab (Advamab) and Trastuzumab (Hersima). All of these are monoclonal antibodies. Rituximab is highly recommended by oncologists as targeted therapy for treatment of one of the cancer Non-Hodgkin lymphoma (NHL) and autoimmune disorder like rheumatoid arthritis (RA).ALKEM LABORATORIES
About Alkem Labs. A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a sparkthat could
ALKEM LABORATORIES
We are a high quality focused organization. Alkem’s vision and culture of high quality obsession reflects in its operations. Our manufacturing operations are focused on producing generics, branded generics, over-the-counter (OTC) products, Active Pharmaceutical Ingredients (APIs) and nutraceuticals. These are available in fullrange of dosage
ALKEM LABORATORIES
Office Suits 4th Floor Block-B Parklands Road. Nairobi Kenya. P.O. Box : 14999-00800. Philippines. Alkem Laboratories Corporation. 5/F Filipino Building, 135 Dela Rosa cor. Legaspi and Bolanos, Legaspi village, Makati, Metro Manila. Australia. Pharmacor Pty Ltd. ABN : 58 121 020 835 A : Suite 803, Level 8, Tower A, The Zenith, 821 PacificALKEM LABORATORIES
Alkem Laboratories Ltd is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical generics, formulations and nutraceuticalsALKEM LABORATORIES
Alkem Urology was launched in July 2017 to cater to the Super specialty segment of Urologist, within the span of 24 Months Alkem Urology has established itself as a serious player in the market ranking 11th in RPM (IMS July 19). We have a key presence in Anti BPH, Stone Management, OAB (Over active bladder) and Erectile dysfunctiontherapies
ALKEM LABORATORIES
CLAVAM, TAXIM-O, TAXIM, PIPZO, SWICH, XONE, XONE-XP & ZOCEF, the pillar brands of Alkem in anti-infective are the key contributors to Indian Pharmaceutical Market. Alkem is the pioneer to launch Arbekacin in India. Arbekacin is a novel semisynthetic aminoglycoside antibiotic, marketed in Japan and Korea since 1990 and have beentreated globally.
ALKEM LABORATORIES
4. Strategies of the Company. Details of Familiarization Programmes held during 2020/2021. The Company has been briefing the independent directors on the issues concerning the industry, to which the Company belongs, developments which takes place and theALKEM LABORATORIES
The Pharma Network LLC and Ascend Laboratories LLC_-USA_FS_2018-19ALKEM LABORATORIES
Vitamins, Mineral & Nutrition. This is one of Alkem’s well established Therapy Areas (TAs). In this TA, we feature amongst the top five companies, possessing an enviable five years CAGR of 12.3%* against 11.4% of segment. These growth numbers are courtesy top-notchbrands such as A
ALKEM LABORATORIESCORPORATE INFOGLOBAL PRESENCER & DMANUFACTURINGINVESTOR DESKMEDIA ROOM Four decades of empowering wellness. With an illustrious journey which stands at striking distance of completing 5 decades, Alkem Laboratories commands the status of one of world's leading global pharmaceutical formulation development, manufacturing and ALKEM LABORATORIESALKEM LABORATORIES Alkem markets and sells products in the United States under our wholly owned subsidiary – Ascend. Other international operations include markets like Australia, Europe, Southeast Asia, Latin America, Africa and CIS. Our products are marketed in about 50 international markets directly through our subsidiaries and indirectly through activeALKEM LABORATORIES
Alkem Cytomed offers three biosimilar drugs i.e. Rituximab (Cytomab), Bevacizumab (Advamab) and Trastuzumab (Hersima). All of these are monoclonal antibodies. Rituximab is highly recommended by oncologists as targeted therapy for treatment of one of the cancer Non-Hodgkin lymphoma (NHL) and autoimmune disorder like rheumatoid arthritis (RA).ALKEM LABORATORIES
Alkem Postal Ballot Results 04.04.2020. Public Notice for Declaration of Record Date for Interim Dividend - FY 2019-20. Newspaper Advertisements. E-paper - 45th AGM Notice. E-paper - Notice of Board Meeting QE 30.06.2019. E-paper -Extract of Financial Result for the QE31.12.2019.
ALKEM LABORATORIESALKEM LABORATORIESALKEM INDIAALKEM LABS USAALKEM LABSHARE PRICE
Alkem Laboratories Ltd is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical generics, formulations and nutraceuticalsALKEM LABORATORIES
Q4 Jan to Mar - 2021. Q4FY21 Press Release. Consolidated Results Mar 21. Standalone Results Mar 21.ALKEM LABORATORIES
Annual Reports. BSE. NSE. ALKEM alkem laboratories limited. 3106.35 4.07 % (121.45) Note: The displayed data may not be real time due tostreaming delays.
ALKEM LABORATORIESALKEM LABORATORIESALKEM LABORATORIES LTDALKEM INDIAALKEM PHARMAALKEM LABS USAALKEM ST LOUIS Diligent and effective international regulatory-compliant operations. Broad and growing portfolio of cGMP API’s available. Contract research, development and international cGMP compliant manufacturing capabilities and services. Full complement of GMP manufacturing technologies and supporting QC analytical capabilities.ALKEM LABORATORIES
Alkem continues to explore market opportunities through licensing arrangements and alliances to draw maximum value from such arrangements. For marketing alliances, Alkem works on non-infringement policies that respect the intellectual property rights of itspartners.
ALKEM LABORATORIES
Alkem commands around 6% of the total revenue generated by this TA. Presently, Alkem is the 3rd largest company in GI Therapy Area (TA) of the Indian Pharmaceutical Market (IPM). Over the years, we have developed several products for GI disorders like GERD, gastric ulcers, constipation, hyperacidity, diarrhoea, worm infestation etc. ALKEM LABORATORIESCORPORATE INFOGLOBAL PRESENCER & DMANUFACTURINGINVESTOR DESKMEDIA ROOM Four decades of empowering wellness. With an illustrious journey which stands at striking distance of completing 5 decades, Alkem Laboratories commands the status of one of world's leading global pharmaceutical formulation development, manufacturing and ALKEM LABORATORIESALKEM LABORATORIES Alkem markets and sells products in the United States under our wholly owned subsidiary – Ascend. Other international operations include markets like Australia, Europe, Southeast Asia, Latin America, Africa and CIS. Our products are marketed in about 50 international markets directly through our subsidiaries and indirectly through activeALKEM LABORATORIES
Alkem Cytomed offers three biosimilar drugs i.e. Rituximab (Cytomab), Bevacizumab (Advamab) and Trastuzumab (Hersima). All of these are monoclonal antibodies. Rituximab is highly recommended by oncologists as targeted therapy for treatment of one of the cancer Non-Hodgkin lymphoma (NHL) and autoimmune disorder like rheumatoid arthritis (RA).ALKEM LABORATORIES
Alkem Postal Ballot Results 04.04.2020. Public Notice for Declaration of Record Date for Interim Dividend - FY 2019-20. Newspaper Advertisements. E-paper - 45th AGM Notice. E-paper - Notice of Board Meeting QE 30.06.2019. E-paper -Extract of Financial Result for the QE31.12.2019.
ALKEM LABORATORIESALKEM LABORATORIESALKEM INDIAALKEM LABS USAALKEM LABSHARE PRICE
Alkem Laboratories Ltd is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical generics, formulations and nutraceuticalsALKEM LABORATORIES
Q4 Jan to Mar - 2021. Q4FY21 Press Release. Consolidated Results Mar 21. Standalone Results Mar 21.ALKEM LABORATORIES
Annual Reports. BSE. NSE. ALKEM alkem laboratories limited. 3106.35 4.07 % (121.45) Note: The displayed data may not be real time due tostreaming delays.
ALKEM LABORATORIESALKEM LABORATORIESALKEM LABORATORIES LTDALKEM INDIAALKEM PHARMAALKEM LABS USAALKEM ST LOUIS Diligent and effective international regulatory-compliant operations. Broad and growing portfolio of cGMP API’s available. Contract research, development and international cGMP compliant manufacturing capabilities and services. Full complement of GMP manufacturing technologies and supporting QC analytical capabilities.ALKEM LABORATORIES
Alkem continues to explore market opportunities through licensing arrangements and alliances to draw maximum value from such arrangements. For marketing alliances, Alkem works on non-infringement policies that respect the intellectual property rights of itspartners.
ALKEM LABORATORIES
Alkem commands around 6% of the total revenue generated by this TA. Presently, Alkem is the 3rd largest company in GI Therapy Area (TA) of the Indian Pharmaceutical Market (IPM). Over the years, we have developed several products for GI disorders like GERD, gastric ulcers, constipation, hyperacidity, diarrhoea, worm infestation etc.ALKEM LABORATORIES
Alkem Cytomed offers three biosimilar drugs i.e. Rituximab (Cytomab), Bevacizumab (Advamab) and Trastuzumab (Hersima). All of these are monoclonal antibodies. Rituximab is highly recommended by oncologists as targeted therapy for treatment of one of the cancer Non-Hodgkin lymphoma (NHL) and autoimmune disorder like rheumatoid arthritis (RA).ALKEM LABORATORIES
About Alkem Labs. A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a sparkthat could
ALKEM LABORATORIES
We are a high quality focused organization. Alkem’s vision and culture of high quality obsession reflects in its operations. Our manufacturing operations are focused on producing generics, branded generics, over-the-counter (OTC) products, Active Pharmaceutical Ingredients (APIs) and nutraceuticals. These are available in fullrange of dosage
ALKEM LABORATORIES
Office Suits 4th Floor Block-B Parklands Road. Nairobi Kenya. P.O. Box : 14999-00800. Philippines. Alkem Laboratories Corporation. 5/F Filipino Building, 135 Dela Rosa cor. Legaspi and Bolanos, Legaspi village, Makati, Metro Manila. Australia. Pharmacor Pty Ltd. ABN : 58 121 020 835 A : Suite 803, Level 8, Tower A, The Zenith, 821 PacificALKEM LABORATORIES
Alkem Laboratories Ltd is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical generics, formulations and nutraceuticalsALKEM LABORATORIES
Alkem Urology was launched in July 2017 to cater to the Super specialty segment of Urologist, within the span of 24 Months Alkem Urology has established itself as a serious player in the market ranking 11th in RPM (IMS July 19). We have a key presence in Anti BPH, Stone Management, OAB (Over active bladder) and Erectile dysfunctiontherapies
ALKEM LABORATORIES
CLAVAM, TAXIM-O, TAXIM, PIPZO, SWICH, XONE, XONE-XP & ZOCEF, the pillar brands of Alkem in anti-infective are the key contributors to Indian Pharmaceutical Market. Alkem is the pioneer to launch Arbekacin in India. Arbekacin is a novel semisynthetic aminoglycoside antibiotic, marketed in Japan and Korea since 1990 and have beentreated globally.
ALKEM LABORATORIES
4. Strategies of the Company. Details of Familiarization Programmes held during 2020/2021. The Company has been briefing the independent directors on the issues concerning the industry, to which the Company belongs, developments which takes place and theALKEM LABORATORIES
The Pharma Network LLC and Ascend Laboratories LLC_-USA_FS_2018-19ALKEM LABORATORIES
Vitamins, Mineral & Nutrition. This is one of Alkem’s well established Therapy Areas (TAs). In this TA, we feature amongst the top five companies, possessing an enviable five years CAGR of 12.3%* against 11.4% of segment. These growth numbers are courtesy top-notchbrands such as A
ALKEM LABORATORIESCORPORATE INFOGLOBAL PRESENCER & DMANUFACTURINGINVESTOR DESKMEDIA ROOM Four decades of empowering wellness. With an illustrious journey which stands at striking distance of completing 5 decades, Alkem Laboratories commands the status of one of world's leading global pharmaceutical formulation development, manufacturing and ALKEM LABORATORIESALKEM LABORATORIES Alkem markets and sells products in the United States under our wholly owned subsidiary – Ascend. Other international operations include markets like Australia, Europe, Southeast Asia, Latin America, Africa and CIS. Our products are marketed in about 50 international markets directly through our subsidiaries and indirectly through activeALKEM LABORATORIES
Alkem Cytomed offers three biosimilar drugs i.e. Rituximab (Cytomab), Bevacizumab (Advamab) and Trastuzumab (Hersima). All of these are monoclonal antibodies. Rituximab is highly recommended by oncologists as targeted therapy for treatment of one of the cancer Non-Hodgkin lymphoma (NHL) and autoimmune disorder like rheumatoid arthritis (RA).ALKEM LABORATORIES
Alkem Postal Ballot Results 04.04.2020. Public Notice for Declaration of Record Date for Interim Dividend - FY 2019-20. Newspaper Advertisements. E-paper - 45th AGM Notice. E-paper - Notice of Board Meeting QE 30.06.2019. E-paper -Extract of Financial Result for the QE31.12.2019.
ALKEM LABORATORIESALKEM LABORATORIESALKEM INDIAALKEM LABS USAALKEM LABSHARE PRICE
Alkem Laboratories Ltd is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical generics, formulations and nutraceuticalsALKEM LABORATORIES
Q4 Jan to Mar - 2021. Q4FY21 Press Release. Consolidated Results Mar 21. Standalone Results Mar 21.ALKEM LABORATORIES
Annual Reports. BSE. NSE. ALKEM alkem laboratories limited. 3106.35 4.07 % (121.45) Note: The displayed data may not be real time due tostreaming delays.
ALKEM LABORATORIESALKEM LABORATORIESALKEM LABORATORIES LTDALKEM INDIAALKEM PHARMAALKEM LABS USAALKEM ST LOUIS Diligent and effective international regulatory-compliant operations. Broad and growing portfolio of cGMP API’s available. Contract research, development and international cGMP compliant manufacturing capabilities and services. Full complement of GMP manufacturing technologies and supporting QC analytical capabilities.ALKEM LABORATORIES
Alkem continues to explore market opportunities through licensing arrangements and alliances to draw maximum value from such arrangements. For marketing alliances, Alkem works on non-infringement policies that respect the intellectual property rights of itspartners.
ALKEM LABORATORIES
Alkem commands around 6% of the total revenue generated by this TA. Presently, Alkem is the 3rd largest company in GI Therapy Area (TA) of the Indian Pharmaceutical Market (IPM). Over the years, we have developed several products for GI disorders like GERD, gastric ulcers, constipation, hyperacidity, diarrhoea, worm infestation etc. ALKEM LABORATORIESCORPORATE INFOGLOBAL PRESENCER & DMANUFACTURINGINVESTOR DESKMEDIA ROOM Four decades of empowering wellness. With an illustrious journey which stands at striking distance of completing 5 decades, Alkem Laboratories commands the status of one of world's leading global pharmaceutical formulation development, manufacturing and ALKEM LABORATORIESALKEM LABORATORIES Alkem markets and sells products in the United States under our wholly owned subsidiary – Ascend. Other international operations include markets like Australia, Europe, Southeast Asia, Latin America, Africa and CIS. Our products are marketed in about 50 international markets directly through our subsidiaries and indirectly through activeALKEM LABORATORIES
Alkem Cytomed offers three biosimilar drugs i.e. Rituximab (Cytomab), Bevacizumab (Advamab) and Trastuzumab (Hersima). All of these are monoclonal antibodies. Rituximab is highly recommended by oncologists as targeted therapy for treatment of one of the cancer Non-Hodgkin lymphoma (NHL) and autoimmune disorder like rheumatoid arthritis (RA).ALKEM LABORATORIES
Alkem Postal Ballot Results 04.04.2020. Public Notice for Declaration of Record Date for Interim Dividend - FY 2019-20. Newspaper Advertisements. E-paper - 45th AGM Notice. E-paper - Notice of Board Meeting QE 30.06.2019. E-paper -Extract of Financial Result for the QE31.12.2019.
ALKEM LABORATORIESALKEM LABORATORIESALKEM INDIAALKEM LABS USAALKEM LABSHARE PRICE
Alkem Laboratories Ltd is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical generics, formulations and nutraceuticalsALKEM LABORATORIES
Q4 Jan to Mar - 2021. Q4FY21 Press Release. Consolidated Results Mar 21. Standalone Results Mar 21.ALKEM LABORATORIES
Annual Reports. BSE. NSE. ALKEM alkem laboratories limited. 3106.35 4.07 % (121.45) Note: The displayed data may not be real time due tostreaming delays.
ALKEM LABORATORIESALKEM LABORATORIESALKEM LABORATORIES LTDALKEM INDIAALKEM PHARMAALKEM LABS USAALKEM ST LOUIS Diligent and effective international regulatory-compliant operations. Broad and growing portfolio of cGMP API’s available. Contract research, development and international cGMP compliant manufacturing capabilities and services. Full complement of GMP manufacturing technologies and supporting QC analytical capabilities.ALKEM LABORATORIES
Alkem continues to explore market opportunities through licensing arrangements and alliances to draw maximum value from such arrangements. For marketing alliances, Alkem works on non-infringement policies that respect the intellectual property rights of itspartners.
ALKEM LABORATORIES
Alkem commands around 6% of the total revenue generated by this TA. Presently, Alkem is the 3rd largest company in GI Therapy Area (TA) of the Indian Pharmaceutical Market (IPM). Over the years, we have developed several products for GI disorders like GERD, gastric ulcers, constipation, hyperacidity, diarrhoea, worm infestation etc.ALKEM LABORATORIES
Alkem Cytomed offers three biosimilar drugs i.e. Rituximab (Cytomab), Bevacizumab (Advamab) and Trastuzumab (Hersima). All of these are monoclonal antibodies. Rituximab is highly recommended by oncologists as targeted therapy for treatment of one of the cancer Non-Hodgkin lymphoma (NHL) and autoimmune disorder like rheumatoid arthritis (RA).ALKEM LABORATORIES
About Alkem Labs. A single idea, which sprouts from a human mind, contains the potential to create marvels that can influence generations. It can redefine rules, it can transform the world. Back in the year 1973, a team of individuals came with such an idea – The idea called Alkem. It was highly potent and resilient, like a sparkthat could
ALKEM LABORATORIES
We are a high quality focused organization. Alkem’s vision and culture of high quality obsession reflects in its operations. Our manufacturing operations are focused on producing generics, branded generics, over-the-counter (OTC) products, Active Pharmaceutical Ingredients (APIs) and nutraceuticals. These are available in fullrange of dosage
ALKEM LABORATORIES
Office Suits 4th Floor Block-B Parklands Road. Nairobi Kenya. P.O. Box : 14999-00800. Philippines. Alkem Laboratories Corporation. 5/F Filipino Building, 135 Dela Rosa cor. Legaspi and Bolanos, Legaspi village, Makati, Metro Manila. Australia. Pharmacor Pty Ltd. ABN : 58 121 020 835 A : Suite 803, Level 8, Tower A, The Zenith, 821 PacificALKEM LABORATORIES
Alkem Laboratories Ltd is a multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical generics, formulations and nutraceuticalsALKEM LABORATORIES
Alkem Urology was launched in July 2017 to cater to the Super specialty segment of Urologist, within the span of 24 Months Alkem Urology has established itself as a serious player in the market ranking 11th in RPM (IMS July 19). We have a key presence in Anti BPH, Stone Management, OAB (Over active bladder) and Erectile dysfunctiontherapies
ALKEM LABORATORIES
CLAVAM, TAXIM-O, TAXIM, PIPZO, SWICH, XONE, XONE-XP & ZOCEF, the pillar brands of Alkem in anti-infective are the key contributors to Indian Pharmaceutical Market. Alkem is the pioneer to launch Arbekacin in India. Arbekacin is a novel semisynthetic aminoglycoside antibiotic, marketed in Japan and Korea since 1990 and have beentreated globally.
ALKEM LABORATORIES
4. Strategies of the Company. Details of Familiarization Programmes held during 2020/2021. The Company has been briefing the independent directors on the issues concerning the industry, to which the Company belongs, developments which takes place and theALKEM LABORATORIES
The Pharma Network LLC and Ascend Laboratories LLC_-USA_FS_2018-19ALKEM LABORATORIES
Vitamins, Mineral & Nutrition. This is one of Alkem’s well established Therapy Areas (TAs). In this TA, we feature amongst the top five companies, possessing an enviable five years CAGR of 12.3%* against 11.4% of segment. These growth numbers are courtesy top-notchbrands such as A
This website uses cookies to provide you with a personalized browsing experience. By using this website you agree to our use of cookies as explained in our Privacy Policy. Please read our Privacy Policy for more information on how we use cookies and how you can manage them.Privacy Policy
Got it
* Corporate Info
* About Us
* Founders Story
* Milestones
* Board of Directors * Awards and Recognition* Quality
* Corporate Social Responsibility* Global Presence
* Overview
* US
* Australia
* Europe
* UK
* Germany
* Latin America
* Chile
* Emerging Markets
* French West Africa* South Africa
* East Africa
* Philippines
* Kazakhstan
* R & D
* Our Purpose
* Research Facilities* Capabilities
* Generics
* Proprietary
* API
* Differentiated Products * Bioequivalence Center* Achievements
* Manufacturing
* Manufacturing Facilities * Regulatory Accreditation* Facility Tour
* Therapies & Products* Therapies
* Anti Infective
* Dermatology
* Diabetology
* Cardiology
* Gastroenterology
* Osteoporosis
* CNS
* Oncology
* Urology
* Gynaecology
* Vitamins, Mineral and Nutrition* Rx Products
* OTC Product
* Patient Corner
* Neurological Diseases & Conditions * Neuro - Psychiatry (CNS)* Neuropathic Pain
* Epilepsy
* Schizophrenia
* Major Depressive Disorder* Anxiety Disorder
* Post Stroke Spasticity* Bipolar Disorder
* Dementia & Alzheimer's Disease* Stroke
* Migraine
* Cardiovascular Health* Hypertension
* Dyslipidemia
* Atrial Fibrillation* Heart Failure
* Diabetes & Metabolic Disorders* Diabetes
* Skin Diseases & Conditions* Acne
* Hair Loss
* Cancer
* Breast Cancer
* Colorectal Cancer
* Prostate Cancer
* Lung Cancer
* Ovarian Cancer
* Lymphoma: Non Hodgkin Lymphoma (NHL)* Brain Tumor
* Multiple Myleoma
* Chemotherapy Induced Nausea & Vomiting (CINV)* Bone Health
* Osteoporosis
* Musculoskeletal Disorder * Ankylosing Spondylitis * Rheumatoid Arthritis* Osteoarthritis
* Urologic Diseases
* Benign Prostate Hyperplasia* Investor Desk
* Financial Overview* Annual Reports
* Annual Returns
* Subsidiary Accounts* Quarterly Results
* Investor Presentations* Earnings Call
* Corporate Governance * Board of Directors * Investor Grievance* Policies
* Committees
* Notices, Forms & Voting Result* ECS Mandate Form
* Shareholding Pattern * Disclosure of Material Events * Unpaid / Unclaimed Dividend Details* Contact Details
* Media Room
* Press Release
* News Updates
* Corporate Press Kit* Careers
* Quick Links
* Ascend Laboratories* Norac Pharma
* Enzene
* Contact Us
* Adverse Event Reporting* Partnership
* Global Locations
* Key Contacts
To Top
* __
* __
* __
* Investor Desk
* Financial Overview* Annual Reports
* Annual Returns
* Subsidiary Accounts* Quarterly Results
* Investor Presentations* Earnings Call
* Corporate Governance * Board of Directors * Investor Grievance* Policies
* Committees
* Notices, Forms & Voting Result* ECS Mandate Form
* Shareholding Pattern * Disclosure of Material Events * Unpaid / Unclaimed Dividend Details* Contact Details
* Media Room
* Press Release
* News Updates
* Corporate Press Kit* Careers
* Quick Links
* Ascend Laboratories * Ascend is US based wholly owned subsidiary of Alkem, provides high-quality and cost effective generics in several therapeuticareas.
Click To Visit Web Site* Norac Pharma
* Norac pharma is a preferred california-based API contract research and manufacturing organization. Click To visit web site* Enzene
* Enzene is technology driven biotechnology company based in pune, india. Click To Visit Web Site* Contact Us
* Adverse Event Reporting* Partnership
* Global Locations
* Key Contacts
* Corporate Info
* About Us
* Founders Story
* Milestones
* Board of Directors * Awards and Recognition* Quality
* Corporate Social Responsibility* Global Presence
* Overview
* US
* Australia
* Europe
* UK
* Germany
* Latin America
* Chile
* Emerging Markets
* French West Africa* South Africa
* East Africa
* Philippines
* Kazakhstan
* R & D
* Our Purpose
* Research Facilities* Capabilities
* Generics
* Proprietary
* API
* Differentiated Products * Bioequivalence Center* Achievements
* Manufacturing
* Manufacturing Facilities * Regulatory Accreditation* Facility Tour
* Therapies & Products* Therapies
* Anti Infective
* Dermatology
* Diabetology
* Cardiology
* Gastroenterology
* Osteoporosis
* CNS
* Oncology
* Urology
* Gynaecology
* Vitamins, Mineral and Nutrition* Rx Products
* OTC Product
* Patient Corner
* Neurological Diseases & Conditions * Neuro - Psychiatry (CNS)* Neuropathic Pain
* Epilepsy
* Schizophrenia
* Major Depressive Disorder* Anxiety Disorder
* Post Stroke Spasticity* Bipolar Disorder
* Dementia & Alzheimer's Disease* Stroke
* Migraine
* Cardiovascular Health* Hypertension
* Dyslipidemia
* Atrial Fibrillation* Heart Failure
* Diabetes & Metabolic Disorders* Diabetes
* Skin Diseases & Hair Disorders* Acne
* Hair Loss
* Cancer
* Breast Cancer
* Colorectal Cancer
* Prostate Cancer
* Lung Cancer
* Ovarian Cancer
* Lymphoma: Non Hodgkin Lymphoma (NHL)* Brain Tumor
* Multiple Myleoma
* Chemotherapy Induced Nausea & Vomiting (CINV)* Bone Health
* Osteoporosis
* Musculoskeletal Disorder * Ankylosing Spondylitis * Rheumatoid Arthritis* Osteoarthritis
* Urologic Diseases
* Benign Prostate Hyperplasia FOUR DECADES OF EMPOWERING WELLNESS With an illustrious journey which stands at striking distance of completing 5 decades, Alkem Laboratories commands the status of one of world's leading global pharmaceutical formulation development, manufacturing and marketing companies from India.Read More
TECHNOLOGICALLY SUPERIOR FOR EMPOWERING HEALTHCARE A technologically advanced and conducive solution becomes necessary to create path-breaking innovations in Healthcare. With over 21 facilities, located in India & USA, Alkem is breaking researchbarriers everyday
Read More
Help transform the future of healthcare Help transform the future of healthcare _— Over 14,500 employees. Operational footprints in over 50 countries. 21 facilities and 6 R&D centres. If you are smart, dynamic and hardworking, you are home at team Alkem. —_Read More
Copyright © Alkem Labs. All Rights Reserved. Privacy Policy | Disclaimer |Sitemap
Best viewed on 1920 x 1080 px, Chrome, Opera, Firefox and EdgeDetails
Copyright © 2024 ArchiveBay.com. All rights reserved. Terms of Use | Privacy Policy | DMCA | 2021 | Feedback | Advertising | RSS 2.0